CPI-005

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCPI-005

Drug Alias Namecardiosphere-derived stem cell therapy (Capricor)CPI-005

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Cardiac myocyte stem cell therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsHeart Failure

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCapricor Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCapricor Inc

Active IndicationsN/A

Inactive IndicationsHeart Failure

ATC CodeN/A